Searched for
GLENMARK PHARMA USFDA
Glenmark Pharma shares in focus after USFDA warning to Indore plantGlenmark Pharmaceuticals disclosed receiving a warning letter from the U.S. FDA for its Indore facility following a February inspection. Th...
Glenmark, Sun Pharma, Zydus recall products in USGlenmark, Sun Pharma, and Zydus are recalling various products in the US due to manufacturing issues and CGMP deviations, according to the ...
Aurobindo, Glenmark, FDC recall products in US market over manufacturing issues: USFDAThe New Jersey-based Aurobindo Pharma USA Inc initiated the Class 1 recall on July 11, it said. As per the US health regulator, a Class I r...
Glenmark gets USFDA nod for generic drug with 180-day exclusivityThe USFDA noted that the Mumbai-based drug firm was the first abbreviated new drug application (ANDA) applicant with a paragraph IV certifi...
Glenmark, Strides Pharma, Cipla recall products in the USThe USFDA noted in its report that the company, a subsidiary of Mumbai-based drug firm, is recalling the affected lot due to "blister packa...
Drug makers Glenmark, Aurobindo recall products in USGlenmark Pharmaceuticals Inc, USA is recalling Fulvestrant injection, Naproxen Sodium Tablets, Chlorzoxazone tablets and Arformoterol Tartr...
Glenmark gets USFDA nod for acne treatment drugGlenmark Pharmaceuticals has received final approval by the United States Food and Drug Administration (USFDA) for Clindamycin Phosphate Ge...
Glenmark Pharma gets USFDA nod for erectile dysfunction treatmentGlenmark Pharmaceuticals Ltd has received final approval from the United States Food and Drug Administration (USFDA) for Tadalafil tablets ...
Glenmark Pharma gets tentative nod from USFDA for cancer treatment drugGlenmark Pharmaceuticals has received tentative approval by the United States Food & Drug Administration (USFDA) for Axitinib tablets in th...
Glenmark Pharma gets USFDA nod for Tacrolimus capsulesGlenmark Pharmaceuticals Inc, USA, has been granted final approval by the United States Food and Drug Administration (USFDA) for Tacrolimus...
Glenmark Pharma gets USFDA nod to market drug for relapsing multiple sclerosisDrug major Glenmark Pharma said it has received final approval from the US health regulator for Dimethyl Fumarate delayed-release capsules,...
Glenmark Pharma gets USFDA nod for prostate cancer treatment drugShares of Glenmark Pharma were trading 0.15 per cent higher at Rs 286.00 apiece on the BSE.
Aurobindo Pharma, Glenmark crack on USFDA observationsAurobindo Pharma plunged 19% after USFDA flagged lack of good manufacturing practices at the Telangana plant.
Glenmark gets USFDA nod for plaque psoriasis treatment drugThe approved product is a generic version of Olux-E Foam, 0.05 per cent.
Glenmark Pharma gets final USFDA nod for migraine drugQuoting IMS data, Glenmark said the approved product has an estimated market size of $87.8 million for the 12 months ended January 2016.
Glenmark gets FDA nod for generic fungal skin infections creamGlenmark Pharma has received final approval from the US health regulator for its cream used for treatment of fungal skin infections.
Glenmark gets tentative USFDA nod for generic psoriasis creamGlenmark said in a statement that the product is the therapeutic equivalent of Danish pharma firm Leo Pharma A/S Dovonex's topical cream of...
- Aurobindo Pharma, Glenmark get USFDA nod for generic asthma drug
Aurobindo, Glenmark today said they have received approval from the US health regulator to manufacture, market generic montelukast tablets.
- Indian pharma companies like Aurobindo and Glenmark set to gain from USFDA nod for asthma drug
Indian drug makers are set to benefit from a decision by the USFDA to allow sale of generic Singulair tablets used for treating asthma and ...
- Glenmark gets USFDA nod for Terbinafine tabs
Glenmark Pharmaceuticals says it has received tentative approval from USFDA for Terbinafine HCL tablets.